Rebekah Boer, NP
Family · Fairmont, MNNPI 1154631653
Payments from drug & device makers
Across 16 payments — averaging $15.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tempus AI, Inc$22
- Pfizer$21
- Dexcom, Inc.$21
- Teva Pharmaceuticals USA, Inc.$17
- AbbVie$16
- Xeris Pharmaceuticals, Inc.$16
- plus $133 from 10 others
What the payments were for
- Food & beverage$246100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tempus AI, Inc | 1 | $22 |
| Pfizer | 1 | $21 |
| Dexcom, Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| AbbVie | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Irhythm Technologies, Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Amgen | 1 | $14 |
| Bayer | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Corium, LLC | 1 | $12 |
| Novartis | 1 | $11 |
| Itamar Medical Inc | 1 | $10 |
How this compares
$246 in reported general payments places this provider in the 75th percentile of 1,121 family providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 17 | $14,697 |
| JardianceEmpagliflozin | 15 | $9,861 |
| Aimovig AutoinjectorErenumab-Aooe | 12 | $8,832 |
| Liothyronine Sodium | 44 | $3,236 |
| Levothyroxine Sodium | 83 | $1,018 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $643 |
| Pravastatin Sodium | 22 | $475 |
| Metoprolol Succinate | 45 | $474 |
| Omeprazole | 38 | $423 |
| Atorvastatin Calcium | 40 | $421 |
| Sertraline Hcl | 31 | $334 |
| Potassium Chloride | 16 | $302 |
| Escitalopram Oxalate | 24 | $244 |
| Losartan Potassium | 28 | $213 |
| Gemfibrozil | 14 | $189 |
Paid to pharmacies, not to this prescriber.
Other family in Fairmont
- Erin HewittMinnetonka$172K
- Julia GourdeMinneapolis$65K
- Robin DontaMinneapolis$60K
- Kristin WeberMinneapolis$35K
- Crista WenischBurnsville$30K
- Kathleen FredellMinneapolis$28K
- Christina RichardsonNorthfield$27K
- Diana CzelMinneapolis$24K
- Alesya ShumkovMinnetonka$22K
- Michelle HigginsStewartville$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.